相关实验视频

Updated: Sep 17, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

胃癌中HER2表达与阿曼人口中临床病理参数的相关性

Asim Qureshi^1,2, Hana Al Julandana³, Sara Al Barkhati

¹Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

|July 3, 2025

概括

这项研究发现,人类表皮生长因子受体2 (HER2) 表达与胃癌特征或阿曼患者的生存结果之间没有显著的联系. 针对HER2的治疗 (trastuzumab) 在这个队列中没有显示出生存益处.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
病理学病理学病理学

背景情况:

胃癌 (GC) 在全球范围内仍然是一个重大的健康挑战.
人类表皮生长因子受体2 (HER2) 是GC患者的一个子集的验证治疗标.
了解HER2表达模式及其与临床特征的相关性对于治疗分层至关重要.

研究的目的:

在胃癌患者中研究HER2表达和临床病理参数之间的关联.
评估HER2表达在胃癌中的预后意义.
评估HER2向治疗 (trastuzumab) 对HER2阳性GC患者的生存的影响.

主要方法:

在2018年至2021年期间治疗的49名胃癌患者的回顾性分析.
评估HER2表达状态.
在HER2状态和临床病理学变量 (组织学等级,转移,组织病理学类型) 和生存数据之间的相关性分析.

主要成果:

在24.4%的胃癌患者中观察到HER2阳性.
在HER2表达和瘤组织学等级,转移的存在或组织病理类型之间没有发现统计学上显著的相关性.
尽管阳性HER2表达,但在接受trastuzumab和不接受trastuzumab的患者之间没有观察到生存率的显著差异.

结论:

在这个阿曼队列中,HER2表达状态与关键的临床病理特征或整体存活率无关.
在这种特定的患者群体中,trastuzumab的疗效需要在更大规模的前性研究中进一步调查.
需要进一步的研究来阐明HER2在胃癌病原和治疗反应中的作用,在不同的种族群体.

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.